Genetic tests: A search for economy of scale

American Journal of Human Genetics

Volumn 59, Issue 2, 1996, Pages 287-288

  Hillner, Bruce ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; EDITORIAL; GENE TECHNOLOGY; GENETIC ANALYSIS; GENETIC SCREENING; HEALTH CARE COST; MEDICAL GENETICS; PRIORITY JOURNAL;

DECISION SUPPORT TECHNIQUES; GENETIC SCREENING; HUMANS; MODELS, ECONOMIC; RETINOBLASTOMA;

EID: 0029815368     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Cuckle HS, Richardson GA, Sheldon TA, Quirke P (1995) Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 311:1460-1464
2. Jenks S (1996) NCI plans national cancer genetics network. J Natl Cancer Inst 88:579-580
3. Laupacis A, Feeny D, Detsky AS, Tugwell PX (1992) How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 146:473-481
4. Lieu TA, Watson SE, Washington AE (1994) The cost-effectiveness of prenatal carrier screening for cystic fibrosis. Obstet Gynecol 84:903-912
5. Mehlman MJ, Botkin JR, Scarrow A, Woodhall A, Kass J, Siebenschuh E (1994) Coverage of genetic technologies under national health reform. Am J Hum Genet 55:1054-1060
6. Noorani HZ, Khan HN, Gallie BL, Detsky AS (1996) Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet 59:301-307 (in this issue)
7. Pauker SG, Kassirer JP (1987) Decision analysis. N Engl J Med 316:250-258
8. Smith TJ, Hillner BE, Desch CE (1993) Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis. J Natl Cancer Inst 85:1460-1474